Effects of High Altitude Clinical Trial
Official title:
Acclimatization of Healthy Subjects During a Stay at 3200 m
Verified date | October 2018 |
Source | University of Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study evaluates respiratory acclimatization in healthy lowlanders staying for 3 weeks at 3200 m.
Status | Completed |
Enrollment | 20 |
Est. completion date | August 9, 2015 |
Est. primary completion date | August 9, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Perfect health - Born, raised and currently living at low altitude (<800m) - Informed consent. Exclusion Criteria: - Any acute or chronic disease - heavy smoking (>20 cigarettes per day). |
Country | Name | City | State |
---|---|---|---|
Kyrgyzstan | National Center of Cardiology and Internal Medicine | Bishkek |
Lead Sponsor | Collaborator |
---|---|
University of Zurich | National Center of Cardiology and Internal Medicine, Kyrgyzstan |
Kyrgyzstan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean nocturnal oxygen saturation measured by pulse oximetry | Difference in mean nocturnal oxygen saturation between night 1 and night 7 | night 7 at 3200 m | |
Secondary | Mean nocturnal oxygen saturation measured by pulse oximetry | Difference in mean nocturnal oxygen saturation between night 1 at 3200 and night 1 at 700 m | night 1 at 3200 m | |
Secondary | Mean nocturnal oxygen saturation measured by pulse oximetry | Difference in mean nocturnal oxygen saturation between night 21 and night 1 at 3200 m | night 21 at 3200 m | |
Secondary | Mean nocturnal oxygen saturation measured by pulse oximetry | Mean nocturnal oxygen saturation during night 1 at 700 m | night 1 at 700 m (low altitude baseline) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01241513 -
Induced Changes in Ventilatory Responsiveness and Altitude Exposure
|
Phase 4 |